These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20447185)

  • 41. Posttransplantation lymphoproliferative disorder of the head and neck: imaging features in seven adults.
    Loevner LA; Karpati RL; Kumar P; Yousem DM; Hsu W; Montone KT
    Radiology; 2000 Aug; 216(2):363-9. PubMed ID: 10924554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roles of F-18-Fluoro-2-Deoxy-Glucose PET/Computed Tomography Scans in the Management of Post-Transplant Lymphoproliferative Disease in Pediatric Patient.
    Xu YF; Yang JG
    PET Clin; 2020 Jul; 15(3):309-319. PubMed ID: 32498987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
    Derlin T; Braubach P; Kreipe HH; Hueper K
    Clin Nucl Med; 2017 Dec; 42(12):988-989. PubMed ID: 29076909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.
    Montes de Jesus FM; Kwee TC; Nijland M; Kahle XU; Huls G; Dierckx RAJO; van Meerten T; Gheysens O; Dierickx D; Vergote V; Noordzij W; Glaudemans AWJM
    Crit Rev Oncol Hematol; 2018 Dec; 132():27-38. PubMed ID: 30447925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasound in abdominal and soft-tissue childhood PTLD (post-transplant lymphoproliferative disease).
    Riebel T; Kebelmann-Betzing C; Scheer I
    Ultraschall Med; 2007 Apr; 28(2):201-5. PubMed ID: 17199182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
    Crocchiolo R; Fallanca F; Giovacchini G; Ferreri AJ; Assanelli A; Verona C; Pescarollo A; Bregni M; Ponzoni M; Gianolli L; Fazio F; Ciceri F
    Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients.
    Lim GY; Newman B; Kurland G; Webber SA
    Radiology; 2002 Mar; 222(3):699-708. PubMed ID: 11867788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
    Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
    Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients.
    Tai R; Tirumani SH; Tirumani H; Shinagare AB; Hornick JL; Ramaiya NH
    Br J Radiol; 2015 Aug; 88(1052):20140861. PubMed ID: 25989696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
    Kim SH; Zeon SK; Choi BW; Kim HW; Won KS; Kim SJ
    Clin Nucl Med; 2011 Jul; 36(7):587-9. PubMed ID: 21637068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A clinical study of lymphoproliferative disorders following allogeneic hematopoietic stem cell transplantation].
    Xu LP; Huang XJ; Liu DH; Chen YH; Shi HX; Chen DB
    Zhonghua Nei Ke Za Zhi; 2007 Dec; 46(12):996-9. PubMed ID: 18478915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of laparoscopic techniques in children with suspected post-transplantation lymphoproliferative disorders.
    Metzelder ML; Schober T; Grigull L; Klein C; Kuebler JF; Ure BM; Maecker-Kolhoff B
    J Laparoendosc Adv Surg Tech A; 2011 Oct; 21(8):767-70. PubMed ID: 21288126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
    Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
    J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL; Zhao JH; Wang C; He ZY; Wang TS; Xing Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
    Li M; Wu N; Liang Y; Zheng R; Liu Y; Zhang WJ; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):288-92. PubMed ID: 19615286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.